Primary Care Clinics in Hartford City, IN Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Iu Health Ball Memorial Physicians Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Pilgrim Blvd, Hartford City, IN 47348 Phone: 765-348-5776 Fax: 765-348-3865 |
Iu Health Ball Memorial Physicians Blackford Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 400 Pilgrim Blvd, Hartford City, IN 47348 Phone: 765-348-5776 Fax: 765-348-3088 |
Open Door Health Services, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 410 Pilgrim Blvd, Hartford City, IN 47348 Phone: 765-286-7000 Fax: 765-213-2769 |
Preferred Family Physicians Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2005 N Walnut St, Hartford City, IN 47348 Phone: 765-348-1100 |
Indiana University Health Jay, Inc. Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 400 Pilgrim Blvd, Hartford City, IN 47348 Phone: 765-348-5776 |
Blackford Community Medical Group Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Pilgrim Blvd, Hartford City, IN 47348 Phone: 765-348-5776 Fax: 765-348-3865 |
Reliant Healthcare Llc Internal Medicine Medicare: Medicare Enrolled Practice Location: 124 N Jefferson St, Hartford City, IN 47348 Phone: 765-347-8279 |
News Archive
Scientists develop model to study the behavior of embryonic tissue
A team of scientists, including M. Lisa Manning, assistant professor of physics in Syracuse University's College of Arts and Sciences, has developed a model for studying tissue-specifically how it organizes into organs and layers during embryonic development.
U.S. Army awards AWR certification for the Masimo Radical-7 and Rad-57 Pulse CO-Oximeters
Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that its Radical-7 and Rad-57 Pulse CO-Oximeters have achieved Airworthiness Release (AWR) Certification from the United States Army.
FDA grants Priority Review status to Takeda's investigational drug vedolizumab for ulcerative colitis
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States Food and Drug Administration has granted Priority Review status for the Biologics License Application for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis.
Recently discovered protein may play key role in obesity and metabolic disease
With unexpected findings about a protein that's highly expressed in fat tissue, scientists at Scripps Research have opened the door to critical new understandings about obesity and metabolism.
› Verified 7 days ago